Inventor · disambiguated record
Joshua M. Donaldson
Also filed as: DONALDSON JOSHUA · DONALDSON JOSHUA M · DONALDSON JOSHUA MICHAEL
8 granted patents·5 pending applications·168 citations·filing 2005–2022
87Inventor score
Top patents by PatentIndex Score
13 records- 0196US10357571B2Development of masked therapeutic antibodies to limit off-target effectsHOPE CITY·Filed 2015·Granted Jul 23, 2019·18 cites·8 claims
- 0296US8962804B2Meditopes and meditope-binding antibodies and uses thereofWILLIAMS JOHN C·Filed 2012·Granted Feb 24, 2015·96 cites·22 claims
- 0394US8895702B2Development of masked therapeutic antibodies to limit off-target effects; application to anti-EGFR antibodiesWILLIAMS JOHN C·Filed 2012·Granted Nov 25, 2014·27 cites·4 claims
- 0490US9669108B2Meditopes and meditope-binding antibodies and uses thereofHOPE CITY·Filed 2014·Granted Jun 6, 2017·9 cites·8 claims
- 0590US7204212B2Camless engine hydraulic valve actuated systemTEMIC AUTOMOTIVE NA INC·Filed 2005·Granted Apr 17, 2007·16 cites·18 claims
- 0681US11311622B2Development of masked therapeutic antibodies to limit off-target effectsHOPE CITY·Filed 2019·Granted Apr 26, 2022·1 cites·5 claims
- 0778US11246942B2Meditopes and meditope-binding antibodies and uses thereofHOPE CITY·Filed 2017·Granted Feb 15, 2022·1 cites·7 claims
- 0876US2023085485A1Design and development of masked therapeutic antibodies to limit off-target effectsHOPE CITY·Filed 2022·Application pending·0 cites
- 0974US2023001003A1Meditopes and meditope-binding antibodies and uses thereofHOPE CITY·Filed 2021·Application pending·0 cites
- 1062US2016152711A1Design and development of masked therapeutic antibodies to limit off-target effects: application to anti-egfr antibodiesHOPE CITY·Filed 2014·Application pending·0 cites
- 1160US11186642B2Development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodiesHOPE CITY·Filed 2017·Granted Nov 30, 2021·0 cites·9 claims
- 1247US2025060488A1Device and system for monitoring geological and structural displacementMthing Pty Ltd·Filed 2022·Application pending·0 cites
- 1337US2011178279A1Development of masked therapeutic antibodies to limit off-target effects: application to anti-egfr antibodiesWILLIAMS JOHN C·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →